Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...

New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one ...

Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...

Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...